Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Afya Ltd (AFYA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $20.39
1 Year Target Price $20.39
| 1 | Strong Buy |
| 2 | Buy |
| 2 | Hold |
| 1 | Sell |
| 3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -40.99% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.59B USD | Price to earnings Ratio 13.11 | 1Y Target Price 20.39 |
Price to earnings Ratio 13.11 | 1Y Target Price 20.39 | ||
Volume (30-day avg) 9 | Beta 0.6 | 52 Weeks Range 14.33 - 19.90 | Updated Date 06/30/2025 |
52 Weeks Range 14.33 - 19.90 | Updated Date 06/30/2025 | ||
Dividends yield (FY) 1.32% | Basic EPS (TTM) 1.34 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.79% | Operating Margin (TTM) 39.79% |
Management Effectiveness
Return on Assets (TTM) 8.16% | Return on Equity (TTM) 16.81% |
Valuation
Trailing PE 13.11 | Forward PE 10.71 | Enterprise Value 1965274921 | Price to Sales(TTM) 0.46 |
Enterprise Value 1965274921 | Price to Sales(TTM) 0.46 | ||
Enterprise Value to Revenue 3.13 | Enterprise Value to EBITDA 7.28 | Shares Outstanding 46586100 | Shares Floating 7491784 |
Shares Outstanding 46586100 | Shares Floating 7491784 | ||
Percent Insiders 68.11 | Percent Institutions 17.91 |
Analyst Ratings
Rating 3 | Target Price 20.39 | Buy 2 | Strong Buy 1 |
Buy 2 | Strong Buy 1 | ||
Hold 2 | Sell 1 | Strong Sell 3 | |
Strong Sell 3 |
Upturn AI SWOT
Afya Ltd
Company Overview
History and Background
Afya Ltd. was founded in 2019, consolidating several medical education institutions in Brazil. It has grown rapidly through acquisitions and organic expansion, becoming a leading player in medical education and related services.
Core Business Areas
- Undergraduate Medical Education: Offers undergraduate medical degrees through its network of campuses in Brazil.
- Continuing Medical Education: Provides continuing education and specialization courses for medical professionals.
- Digital Health Services: Offers digital health solutions, including telemedicine and practice management tools.
Leadership and Structure
The leadership team consists of experienced executives in education, healthcare, and finance. The organizational structure is designed to manage its geographically dispersed campuses and diverse business units.
Top Products and Market Share
Key Offerings
- Undergraduate Medical Degrees: Afya's core offering, providing full medical degrees. Market share data is fragmented across various regions in Brazil, but Afya holds a significant portion, estimated at around 20% overall. Competitors include Estu00e1cio, Unip, and other regional medical schools. Revenue is the largest portion of their overall revenue.
- Specialization Programs: Post-graduate medical education programs. The market is highly competitive with many providers. Revenue from this segment is growing, but smaller compared to the core undergraduate revenue. Competitors include MedCof and other specialized medical education providers.
- Digital Health Platform iClinic: Software as a service platform for physicians in Brazil with tools like EHR and scheduling tools. They have over 30,000 active users. There is not much market data. Competitors include Memed, Doctoralia, and Feegow.
Market Dynamics
Industry Overview
The Brazilian medical education market is growing, driven by increasing demand for healthcare professionals and limited access to quality education. The market is fragmented, with a mix of private and public institutions.
Positioning
Afya Ltd. is positioned as a premium provider of medical education, focusing on quality and innovation. It has a competitive advantage through its established brand, extensive network, and integrated digital platform.
Total Addressable Market (TAM)
The TAM for medical education in Brazil is estimated to be in the billions of USD annually. Afya is well-positioned to capture a significant share of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive network of campuses
- Integrated digital platform
- Experienced management team
- Proven track record of acquisitions
Weaknesses
- Geographic concentration in Brazil
- Reliance on government regulations
- Potential for increased competition
- High capital expenditure requirements
- Dependence on accreditation for programs
Opportunities
- Expansion into new geographic markets within Brazil
- Development of new digital health solutions
- Acquisition of complementary businesses
- Partnerships with hospitals and healthcare providers
- Growing demand for telemedicine solutions
Threats
- Changes in government regulations
- Increased competition from other medical schools
- Economic downturn in Brazil
- Currency fluctuations
- Negative impact on enrollment due to global events
Competitors and Market Share
Key Competitors
- Estu00e1cio (YDUQ3.SA)
- u00c2nima Educau00e7u00e3o (ANIM3.SA)
- Ser Educacional (SEER3.SA)
Competitive Landscape
Afya has an advantage with a strong focus on medical education and its integrated digital platform. Competitors are larger, more diversified education companies.
Major Acquisitions
MedCof
- Year: 2020
- Acquisition Price (USD millions): 270
- Strategic Rationale: Strengthen Afya's postgraduate medical education offerings.
iClinic
- Year: 2019
- Acquisition Price (USD millions): 32
- Strategic Rationale: Expand Afya's digital health ecosystem.
Growth Trajectory and Initiatives
Historical Growth: Afya Ltd. has experienced rapid growth through acquisitions and organic expansion since its inception.
Future Projections: Analysts project continued growth for Afya Ltd., driven by increasing demand for medical education and the company's expansion into new markets.
Recent Initiatives: Afya Ltd. has recently focused on expanding its digital health platform and acquiring new medical education institutions.
Summary
Afya Ltd. is a growing medical education company in Brazil with a strong brand and integrated digital platform. Its acquisition strategy has fueled rapid expansion, but reliance on Brazil exposes it to economic and regulatory risks. Growth is projected to continue, particularly in digital health, however increased competition is a factor to monitor. Overall, Afya is well-positioned, but needs to diversify geographically and manage its debt effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Analyst Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br | ||
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.